Anika Therapeutics Inc (ANIK)

EBITDA Margin

14.98%

Quarterly · Period ending:

ANIK logo

ANIK EBITDA Margin

Latest reported14.98%
ANIK Quarterly EBITDA Margin (-400.00% → 14.98%)
High-resolution chart · PNG

ANIK ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-87.5369%
-94.9741%
33.3024%
-52.3744%
-5.1124%
-19.5883%
6.6667%
0%
6.1407%
18.75%
23.5294%
18.75%
45.6522%
21.4286%
51.6667%
-12.5%
20%
15.7895%
-72.7273%
-38.4615%
-40%
-100%
-44.4444%
-88.8889%
-44.4444%
-14.2857%
-44.4444%
-36.3636%
-50%
-14.2857%
-8.3333%
-23.8095%
-400%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.